Pharmacists in Robbinsdale, Minnesota


28 Pharmacists found in Robbinsdale
female pharmacist

Mary Jo Vierkant, PHARMD, MED, BS


Pharmacist
3300 Oakdale Avenue North, North Memorial Medical Center Pharmacy, Robbinsdale, MN 55422
763-520-5200     763-520-4926

male pharmacist

Dr. Matthew Thunselle, PHARM.D.


Pharmacist
3300 Oakdale Ave N, Robbinsdale, MN 55422
763-520-5200    

male pharmacist

Preston Scott Angen-determan, PHARMD


Pharmacist
3300 Oakdale Ave N, Robbinsdale, MN 55422
763-520-5200    



female pharmacist

Dr. Rachel Elizabeth Rockwell, PHARMD


Pharmacist
3505 Bottineau Blvd, Robbinsdale, MN 55422
612-287-7201     612-287-7239

female pharmacist

Sally Kastner


Pharmacist
4100 W Broadway Ave, Robbinsdale, MN 55422
763-537-9487    

male pharmacist

Scott Gregory Seaburg, PHARMACIST


Pharmacist
3300 Oakdale Ave N, Robbinsdale, MN 55422
763-520-5200    

male pharmacist

Scott A Chapman, PHARM.D.


Pharmacist - Pharmacotherapy
3300 Oakdale Ave N, Robbinsdale, MN 55422
763-520-3961    

female pharmacist

Dr. Shannon Marie Burton, PHARMD


Pharmacist
4152 Lakeland Ave N, Robbinsdale, MN 55422
763-535-2459    

male pharmacist

Shawn M Mcgurran, PHARM.D.


Pharmacist
3300 Oakdale Ave N, Robbinsdale, MN 55422
763-520-5634    

female pharmacist

Tiffany Capouch, PHARMD


Pharmacist
3300 Oakdale Ave N, Robbinsdale, MN 55422
763-520-5200    

female pharmacist

Uzoma Ginika Osuoha


Pharmacist
4100 W Broadway Ave, Robbinsdale, MN 55422
763-537-9487    

male pharmacist

Mr. Xoua Kue, PHARMD


Pharmacist
3505 Bottineau Blvd, Robbinsdale, MN 55422
612-287-7201     612-287-7239


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.